Abstract

This is a report of a cluster randomized clinical trial evaluating the effectiveness of a church-based educational intervention aimed at improving African Americans’ (AA) participation in clinical trials. Two hundred and twenty-one AA subjects ages ≥50 years from six predominantly AA churches were randomized to intervention or control condition. The intervention included three educational sessions about clinical trials and health disparities; control participants completed questionnaires. Primary endpoints of the study were differences in individual subjects' intentions to obtain clinical trial information and intention to join a clinical trial, as determined by 10 point scale items at baseline, three and six months. A statistically significant increase in the intention to obtain clinical trial information at the three and six month time points was observed in the intervention group, but not the control group. Older participants (65–95 years) were less likely than younger participants (50–64 years) to increase their motivation to seek clinical trial information by the three and six month time points. No significant increases were observed in intention to join clinical trials. This randomized trial shows that AA church-based educational interventions are likely to increase the motivation of AA subjects to obtain clinical trial information and are therefore potentially effective at ameliorating the underrepresentation of AA subjects in clinical trials.

Highlights

  • Despite decades of significant medical advances that have resulted in approval of novel prevention strategies, therapeutics, and medical devices, clinical trials continue to be challenged by underrepresentation of racial and ethnic minority participants [1,2]

  • Members of the intervention group participated in three information sessions about clinical trials and related health issues guided by church leaders, subject matter experts, and clinical researchers

  • There were no significant differences in gender, education, or income between the control and intervention groups (Table 2)

Read more

Summary

Introduction

Despite decades of significant medical advances that have resulted in approval of novel prevention strategies, therapeutics, and medical devices, clinical trials continue to be challenged by underrepresentation of racial and ethnic minority participants [1,2]. Recent data demonstrate that overall participation rates among racial/ethnic minorities continue to lag behind those of other groups for various types of clinical trials [1,3,4]. Enrollment rates are lower among the elderly (typically defined as those ě70 years) when compared to younger participants [5,6,7], and lower among women than men in cardiology trials [1,4]. Res. Public Health 2016, 13, 41; doi:10.3390/ijerph13010041 www.mdpi.com/journal/ijerph

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call